Cyanotech Corp.
Cyanotech Corporation produces natural products from microalgae worldwide. Products include BioAstin Hawaiian Astaxanthin for skin, eye, joint, and immune health, and Hawaiian Spirulina Pacifica for energy, immune system, and cardiovascular health. The company also offers contract extraction and research services.
Overview
Strengths
- Skin in the game: insiders own 33% of the shares, aligning management with shareholders.
- Improving fundamentals over the last year: return on assets up 7.3 points, gross margin up 2.6 points and asset turnover up 12.2%.
Weaknesses
- Operating profit does not cover interest expense.
- Our discounted cash flow model finds no value to support the current price: operating profit does not cover interest expense.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 3 of the last 6 years.
- Unstable profitability: operating margin ranged from -20% to 7% over the last 6 years, with operating losses in 3 of them.
- Shareholder dilution: the share count has grown by 5.1% a year over the last three years.
Key Financial Data